On June 12-14th, at the Intercontinental New York Times Square, industry leaders from both innovator and biosimilar companies will convene at ACI’s 8th Annual Summit on Biosimilars to discuss the future of biosimilars and formulate solutions to the complex regulatory and patent challenges ahead. Goodwin is a proud sponsor of the summit and partner Rob Cerwinski is a featured speaker on the panel, Shall we Dance: Mastering the “Steps” of the BPCIA While Avoiding Common Pitfalls. Several other Goodwin attorneys will also be attending the summit.

For additional information, please click here.